abrdn Life Sciences Investors

16,89 €
▼ -0,15 €
(-0,91%)
ISIN US87911K1007 Typ ETF Stand 18.09.2026

Aktueller Kurs

Lade Kursdaten...

Beschreibung

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Profil

Name
abrdn Life Sciences Investors
ISIN
US87911K1007
Kategorie
Global Equity
Fokus
Life Sciences
Ausschüttungsfrequenz
4
Dividendenrendite
8.19%
Anzahl Positionen
101
Beta (1J)
0.34
Beta (3J)
0.56
Beta (5J)
0.63
Volatilität
0.23%
Top-Holdings
GILEAD SCIENCES INC 6.73%
AMGEN INC 6.45%
Regeneron Pharmaceuticals, Inc. 6.29%
Vertex Pharmaceuticals Incorporated 5.71%
ASTRAZENECA PLC-SPONS ADR 3.8%
Biogen Inc. 3.24%
Alnylam Pharmaceuticals, Inc. 3.13%
Sarepta Therapeutics, Inc. 2.93%
BioMarin Pharmaceutical Inc. 2.81%
BIONTECH SE-ADR 2.72%
ARGENX SE - ADR 2.49%
State Street Global Advisors 2.26%
Illumina, Inc. 1.88%
Summit Therapeutics Inc. 1.83%
Insmed Incorporated 1.8%
Neurocrine Biosciences, Inc. 1.69%
UNIQURE NV 1.65%
Intra-Cellular Therapies, Inc. 1.6%
VAXCYTE INC 1.45%
CYTOKINETICS INC 1.22%
Tarsus Pharmaceuticals, Inc. 1.22%
XENON PHARMACEUTICALS INC 1.12%
Immunovant, Inc. 1.03%
MODERNA INC 1%
ULTRAGENYX PHARMACEUTICAL IN 1%
Ionis Pharmaceuticals, Inc. 0.94%
Arrowhead Pharmaceuticals, Inc. 0.88%
DENALI THERAPEUTICS INC 0.85%
AKERO THERAPEUTICS INC 0.72%
IDEAYA BIOSCIENCES INC 0.69%
KRYSTAL BIOTECH INC 0.68%
Geron Corporation 0.68%
Alkermes plc 0.64%
Axsome Therapeutics, Inc. 0.62%
GUARDANT HEALTH INC 0.62%
MEDPACE HOLDINGS INC 0.57%
Codexis, Inc. 0.57%
Oculis Holding AG 0.54%
CO-OPERATIVE BANK HOLDN 0.53%
ARDELYX INC 0.53%
Arcutis Biotherapeutics, Inc. 0.52%
XENCOR INC 0.52%
ADAPTIVE BIOTECHNOLOGIES 0.52%
CRINETICS PHARMACEUTICALS IN 0.52%
Halozyme Therapeutics, Inc. 0.52%
Quanterix Corporation 0.52%
Travere Therapeutics, Inc. 0.51%
Nuvalent, Inc. 0.5%
SCHOLAR ROCK HOLDING CORP 0.5%
Edgewise Therapeutics, Inc. 0.48%
Amylyx Pharmaceuticals, Inc. 0.47%
BEONE MEDICINES LTD-ADR 0.41%
PERSONALIS INC 0.4%
RHYTHM PHARMACEUTICALS INC 0.38%
ELI LILLY & CO 0.36%
Structure Therapeutics Inc. 0.36%
Arvinas, Inc. 0.35%
DWS GOVERNMENT AND AGENCY SECURITIES PORTFOLIO DWS GOVERNMENT CASH INSTITUTIONAL SHARES 0.33%
CBOE GLOBAL MARKETS, INC. 0.32%
SYNDAX PHARMACEUTICALS INC 0.31%
Avidity Biosciences, Inc. 0.31%
MERUS NV 0.31%
89bio, Inc. 0.3%
Abeona Therapeutics Inc. 0.29%
Janux Therapeutics, Inc. 0.29%
TScan Therapeutics, Inc. 0.28%
IMMATICS NV 0.25%
Natera, Inc. 0.24%
Iovance Biotherapeutics, Inc. 0.23%
AVANTOR INC 0.21%
Vigil Neuroscience, Inc. 0.21%
Vir Biotechnology, Inc. 0.21%
Tenaya Therapeutics, Inc. 0.2%
Allogene Therapeutics, Inc. 0.18%
Chicago Mercantile Exchange 0.15%
Dyne Therapeutics, Inc. 0.14%
Marinus Pharmaceuticals, Inc. 0.14%
CARGO Therapeutics, Inc. Common Stock 0.14%
GRAIL INC 0.13%
EYEPOINT INC 0.12%
Thermo Fisher Scientific Inc. 0.11%
Inozyme Pharma, Inc. 0.11%
Pyxis Oncology, Inc. 0.1%
Rallybio Corporation 0.08%
Premium Green PLC 0.08%
Corbus Pharmaceuticals Holdings, Inc. 0.07%
Caribou Biosciences, Inc. 0.07%
NOVAVAX INC 0.05%
Chinook Therapeutics Inc 0.03%
Praxis Precision Medicines, Inc. 0.03%
ALX Oncology Holdings Inc. 0.03%
Nkarta, Inc. 0.02%
ORUKA THERAPEUTICS INC 0.01%
Mural Oncology plc 0.01%
Affimed N.V. 0.01%
NOVABRIDGE BIOSCIENCES 0.01%
Galera Therapeutics, Inc. 0%
CONTRA FUSION PHARMACE 0%
TETRAPHASE PHARMACEUTICALS INC 0%
INEOS US PETROCHEM LLC 0%
CONTRA SPECTRUM PHARMA 0%

Performance

Keine Performance Daten vorhanden.

So viel Cashback zahlen wir für Ihren Fonds

Nach oben scrollen